A program to support couples dealing with dementia
Resilient Together for Dementia: A Live Video Resiliency Dyadic Intervention for Persons With Dementia and Their Care-partners Early After Diagnosis
NA · Icahn School of Medicine at Mount Sinai · NCT06619327
This study is testing a new program called Resilient Together for Dementia to see if it can help couples cope better with the emotional challenges of dementia.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Icahn School of Medicine at Mount Sinai (other) |
| Locations | 1 site (New York, New York) |
| Trial ID | NCT06619327 on ClinicalTrials.gov |
What this trial studies
This intervention focuses on couples where one partner has been diagnosed with dementia, aiming to reduce emotional distress and improve quality of life for both partners. The Resilient Together for Dementia (RT-D) program will be delivered via live video and is designed to prevent chronic emotional distress in at-risk dyads. A pilot randomized control trial will assess the feasibility and preliminary efficacy of RT-D compared to a minimally enhanced educational control. The study will involve 50 dyads and will evaluate various outcomes to inform future research phases.
Who should consider this trial
Good fit: Ideal candidates include English-speaking couples living together, where one partner has a recent diagnosis of early-stage dementia and experiences significant emotional distress.
Not a fit: Patients who are deemed inappropriate by the neurology team or have co-occurring terminal illnesses may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly improve the emotional well-being and quality of life for couples affected by dementia.
How similar studies have performed: Other studies have shown promise in using dyadic interventions for emotional distress in dementia care, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Recent (\~3 month) chart documented ADRD diagnosis, * ADRD symptom onset after age 65 * Cognitive assessment scores and symptoms consistent with early stage dementia, as determined by the Clinical Dementia Rating Scale scores of .5 or 1.0 * Cognitive awareness of their problems (as determined by the treating neurologist), and ability to understand study and research protocol, as determined by a standardized teach-back method assessment Additional inclusion criteria for dyads are: * English speaking adults (18 years or older) * Dyad lives together * At least one partner endorses clinically significant emotional distress during screening (\>7 on Hospital Anxiety and Depression scale subscales or \<5 on the Geriatric Depression Scale) Exclusion Criteria: * Patient is deemed inappropriate by the neurology team * Either partner has a co-occurring terminal illness * Patient was diagnosed with forms of dementia with clinical profiles that would preclude participation (e.g., Frontotemporal Dementia- behavioral variant), as determined by treatment team.
Where this trial is running
New York, New York
- Brain Injury Research Center at Mount Sinai — New York, New York, United States (RECRUITING)
Study contacts
- Principal investigator: Sarah Bannon, PhD — Icahn School of Medicine at Mount Sinai
- Study coordinator: Sarah M. Bannon, PhD
- Email: sarah.bannon@mountsinai.org
- Phone: 212-241-0787
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Dementia, Care partners, Dyads, Emotional distress, Quality of life, Couples